Literature DB >> 12608713

Effects of repeated administration of baclofen to rats on GABAB receptor binding sites and subunit expression in the brain.

Anders Lehmann1, Jan P Mattsson, Anders Edlund, Thore Johansson, A Jonas Ekstrand.   

Abstract

Repeated stimulation of the GABAB receptor with baclofen frequently produces tolerance, the underlying mechanisms of which are poorly understood. The purpose of the present work was to determine whether repeated administration of baclofen to rats is accompanied by changes in cerebral GABAB receptor binding sites, mRNA for the subunits GABAB(1) and GABAB(2), and protein levels for these subunits. Rats were injected with placebo or baclofen (20 micromol/kg subcutaneously) once daily for 14 days. Decreases in body temperature were measured as an index of pharmacological effects of baclofen. Binding of radiolabeled GABA to GABAB receptors was quantitated in brain membranes, mRNA levels were determined using quantitative real-time PCR, and GABAB receptor protein levels were assessed with Western blot analysis. Baclofen caused a decline in temperature amounting to approximately 2.5 degrees C after the first dose. This effect was partly lost after the fifth and abolished after the seventh injection. Despite the complete development of tolerance, there were no significant alterations in GABAB receptor binding sites (number or affinity) or mRNA levels for the subtypes GABAB(1a), GABAB(1b), or GABAB(2). Receptor protein levels were also unchanged. It is concluded that baclofen induces tolerance through mechanisms other than down-regulation of GABAB receptor transcription or translation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12608713     DOI: 10.1023/a:1022353923578

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  31 in total

Review 1.  GABAB receptors: a new paradigm in G protein signaling.

Authors:  A Couve; S J Moss; M N Pangalos
Journal:  Mol Cell Neurosci       Date:  2000-10       Impact factor: 4.314

Review 2.  Opiate tolerance and dependence: receptors, G-proteins, and antiopiates.

Authors:  L M Harrison; A J Kastin; J E Zadina
Journal:  Peptides       Date:  1998       Impact factor: 3.750

3.  No development of tolerance to analgesia by repeated administration of H1 antagonists.

Authors:  C Ghelardini; N Galeotti; A Bartolini
Journal:  Life Sci       Date:  1998       Impact factor: 5.037

Review 4.  Turning off the signal: mechanisms that attenuate signaling by G protein-coupled receptors.

Authors:  E F Grady; S K Böhm; N W Bunnett
Journal:  Am J Physiol       Date:  1997-09

5.  The chemistry and kinetics of Lioresal.

Authors:  J W Faigle; H Keberle
Journal:  Postgrad Med J       Date:  1972-10       Impact factor: 2.401

6.  Activation of the GABA(B) receptor inhibits transient lower esophageal sphincter relaxations in dogs.

Authors:  A Lehmann; M Antonsson; M Bremner-Danielsen; M Flärdh; L Hansson-Brändén; L Kärrberg
Journal:  Gastroenterology       Date:  1999-11       Impact factor: 22.682

7.  Enhancement of morphine analgesia by the GABAB agonist baclofen.

Authors:  N C Gordon; R W Gear; P H Heller; S Paul; C Miaskowski; J D Levine
Journal:  Neuroscience       Date:  1995-11       Impact factor: 3.590

8.  Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence.

Authors:  L M Bohn; R R Gainetdinov; F T Lin; R J Lefkowitz; M G Caron
Journal:  Nature       Date:  2000-12-07       Impact factor: 49.962

9.  Gamma-aminobutyric acid binding to receptor sites in the rat central nervous system.

Authors:  S R Zukin; A B Young; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1974-12       Impact factor: 11.205

10.  Intrathecal baclofen down-regulates GABAB receptors in the rat substantia gelatinosa.

Authors:  J S Kroin; G D Bianchi; R D Penn
Journal:  J Neurosurg       Date:  1993-10       Impact factor: 5.115

View more
  11 in total

1.  Subchronic administration and combination metabotropic glutamate and GABAB receptor drug therapy in fragile X syndrome.

Authors:  Laura K K Pacey; Sujeenthar Tharmalingam; David R Hampson
Journal:  J Pharmacol Exp Ther       Date:  2011-06-02       Impact factor: 4.030

2.  Chronic baclofen desensitizes GABA(B)-mediated G-protein activation and stimulates phosphorylation of kinases in mesocorticolimbic rat brain.

Authors:  Bradley M T Keegan; Thomas J R Beveridge; Jeffrey J Pezor; Ruoyu Xiao; Tammy Sexton; Steven R Childers; Allyn C Howlett
Journal:  Neuropharmacology       Date:  2015-02-25       Impact factor: 5.250

3.  Growth hormone responses to GABAB receptor challenge with baclofen and impulsivity in healthy control and personality disorder subjects.

Authors:  Royce Lee; Berdine Chong; Emil Coccaro
Journal:  Psychopharmacology (Berl)       Date:  2010-12-22       Impact factor: 4.530

4.  Efficacy and side effects of baclofen and the novel GABAB receptor positive allosteric modulator CMPPE in animal models for alcohol and cocaine addiction.

Authors:  Valentina Vengeliene; Tatiane T Takahashi; Olga A Dravolina; Irina Belozertseva; Edwin Zvartau; Anton Y Bespalov; Rainer Spanagel
Journal:  Psychopharmacology (Berl)       Date:  2018-04-12       Impact factor: 4.530

5.  Cortical stimulation causes long-term changes in H-reflexes and spinal motoneuron GABA receptors.

Authors:  Yu Wang; Yi Chen; Lu Chen; Jonathan R Wolpaw; Xiang Yang Chen
Journal:  J Neurophysiol       Date:  2012-08-29       Impact factor: 2.714

6.  Differential sensitivity to the motor and hypothermic effects of the GABA B receptor agonist baclofen in various mouse strains.

Authors:  Laura H Jacobson; John F Cryan
Journal:  Psychopharmacology (Berl)       Date:  2005-01-25       Impact factor: 4.530

7.  GABAB Receptors: Anxiety and Mood Disorders.

Authors:  Daniela Felice; John F Cryan; Olivia F O'Leary
Journal:  Curr Top Behav Neurosci       Date:  2022

8.  Differential development of tolerance to the functional and behavioral effects of repeated baclofen treatment in rats.

Authors:  T J R Beveridge; H R Smith; L J Porrino
Journal:  Pharmacol Biochem Behav       Date:  2013-03-13       Impact factor: 3.533

9.  Positive allosteric modulation of the GABA(B) receptor by GS39783 attenuates the locomotor stimulant actions of ethanol and potentiates the induction of locomotor sensitization.

Authors:  Lauren C Kruse; David N Linsenbardt; Stephen L Boehm
Journal:  Alcohol       Date:  2012-05-02       Impact factor: 2.405

10.  Allosteric modulators of GABA(B) receptors: mechanism of action and therapeutic perspective.

Authors:  Jean-Philippe Pin; Laurent Prézeau
Journal:  Curr Neuropharmacol       Date:  2007-09       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.